Annual Review of Biochemistry
This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Annual Review of Biochemistry | |
|---|---|
 | |
| Title | Annual Review of Biochemistry |
| Discipline | Biochemistry |
| Abbreviation | Annu. Rev. Biochem. |
| Publisher | Annual Reviews |
| Country | United States |
| History | 1932–present |
| Frequency | Annual |
Annual Review of Biochemistry is a peer-reviewed scientific journal that publishes comprehensive review articles covering developments in Biochemistry and related fields. Founded in the early 20th century by scholars associated with institutions such as Stanford University, Harvard University, and Johns Hopkins University, the journal established itself as a venue for authoritative syntheses by leaders from Massachusetts Institute of Technology, California Institute of Technology, and University of California, Berkeley. Over decades, contributors have included investigators from Rockefeller University, Columbia University, University of Oxford, University of Cambridge, Max Planck Society, and Princeton University, making it influential among researchers at Yale University, University of Chicago, and University of Pennsylvania.
History
The journal was initiated during a period when reviews by scholars at Rockefeller Institute and Carnegie Institution were reshaping biomedical literature, paralleling efforts at Royal Society and National Academy of Sciences. Early volumes featured work by figures associated with Cornell University, University of Michigan, and University of Toronto, and adopted editorial practices influenced by committees at American Chemical Society and National Institutes of Health. Throughout the mid-20th century, editors recruited authors from Pasteur Institute, Institut Curie, University of California, San Francisco, and Imperial College London, reflecting transatlantic networks including Ludwig Maximilian University of Munich and ETH Zurich. The journal's growth tracked advances occurring at laboratories such as Cold Spring Harbor Laboratory, Salk Institute, and Waksman Institute, and paralleled discoveries recognized by awards like the Nobel Prize and honors from the Royal Society. By the late 20th century, editorial stewardship engaged scholars from Massachusetts General Hospital, Brigham and Women's Hospital, and Mount Sinai Hospital.
Scope and Content
The journal covers synthetic reviews on topics spanning molecular mechanisms explored at Max Planck Institute, structural studies from groups at European Molecular Biology Laboratory, enzymology from labs allied with University of California, San Diego, metabolic regulation studied by teams at Johns Hopkins School of Medicine, and signaling research from centers such as Dana-Farber Cancer Institute. Articles synthesize primary research from investigators at Scripps Research, University of Texas Southwestern Medical Center, Karolinska Institute, Weizmann Institute of Science, and Seoul National University. Content ranges to include macromolecular complexes characterized by facilities like Brookhaven National Laboratory, biochemical genetics advanced at Cold Spring Harbor Laboratory, and techniques originating in departments at University of Illinois Urbana-Champaign and University of Wisconsin–Madison.
Editorial Process and Policies
Editorial policies are administered by an editorial committee modeled on governance seen at National Academy of Sciences review panels and advisory boards at Howard Hughes Medical Institute. Prospective authors are invited based on reputations established at institutions such as Stanford School of Medicine, Harvard Medical School, Yale School of Medicine, and UCSF School of Medicine. Peer review involves external reviewers from universities including Columbia University Irving Medical Center, Duke University School of Medicine, Vanderbilt University Medical Center, and University of Melbourne. Conflicts of interest and disclosure norms reflect standards promoted by societies like American Society for Biochemistry and Molecular Biology and regulatory principles comparable to those in guidelines from World Health Organization committees and funding agencies such as National Science Foundation and Wellcome Trust.
Publication and Access
Published annually by Annual Reviews (publisher), the journal is distributed to libraries at institutions including British Library, Library of Congress, and university systems at University of California and University of Oxford. Digitized archives parallel collections hosted by consortia such as HathiTrust and interfaces used by subscribers at JSTOR and libraries subscribing via agents like EBSCO Information Services. Access models have evolved alongside initiatives at Open Access advocates and consortial agreements seen at Coalition S and national libraries; subscription, consortium, and open-access options reflect negotiations similar to contracts negotiated by Elsevier and Springer Nature for other scholarly titles.
Impact and Reception
The journal has been cited by work from laboratories at Broad Institute, European Bioinformatics Institute, National Institutes of Health, and corporate research teams at Pfizer, GlaxoSmithKline, Amgen, and Merck & Co.. Citation metrics place it among outlets read by scientists at MRC Laboratory of Molecular Biology, Riken, CERN-adjacent biophysical programs, and translational centers such as Fred Hutchinson Cancer Center. Reviews have influenced research directions at grant-making bodies like Wellcome Trust, Howard Hughes Medical Institute, and policy units within European Commission science frameworks. Scholarly reception includes frequent referencing in textbooks produced by authors from Garland Science and course syllabi at MIT, UC Berkeley, and Imperial College London.
Notable Volumes and Articles
Seminal articles have synthesized breakthroughs like protein structure work linked to Rosalind Franklin-era research, enzymology associated with investigators from Arthur Kornberg-adjacent labs, and signaling pathways credited to groups at Cold Spring Harbor Laboratory and MEMC. Landmark reviews have been authored by scholars from Francis Crick Institute, Salk Institute, Ludwig Institute for Cancer Research, Institute of Cancer Research, and contributors who later received Nobel Prize in Physiology or Medicine recognition. Special volumes have compiled themes on topics championed at international conferences hosted by Gordon Research Conferences, Cold Spring Harbor Laboratory meetings, and EMBO symposia.
Editors-in-Chief and Editorial Board
Editors-in-chief have historically come from institutions including Harvard University, Stanford University School of Medicine, University of California, San Francisco, Princeton University, and Yale University School of Medicine. Editorial board membership typically draws senior scientists affiliated with Broad Institute, Max Planck Society, Karolinska Institute, Weill Cornell Medicine, Columbia University, Johns Hopkins University School of Medicine, ETH Zurich, University of Cambridge, University of Tokyo, and Peking University. The board’s composition reflects international representation from centers in Germany, France, Japan, China, United Kingdom, and Australia.
Category:Biochemistry journals